Reduction of glutamatergic activity through cholinergic dysfunction in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice

Cholinergic activation can enhance glutamatergic activity in the hippocampus under pathologic conditions, such as Alzheimer’s disease. The aim of the present study was to elucidate the relationship between glutamatergic neural functional decline and cholinergic neural dysfunction in the hippocampus....

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kengo, Ohi, Yoshiaki, Sato, Toyohiro, Tsuda, Yo, Madokoro, Yuta, Mizuno, Masayuki, Adachi, Kenichi, Uchida, Yuto, Haji, Akira, Ojika, Kosei, Matsukawa, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649636/
https://www.ncbi.nlm.nih.gov/pubmed/36357544
http://dx.doi.org/10.1038/s41598-022-23846-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649636/
https://www.ncbi.nlm.nih.gov/pubmed/36357544
http://dx.doi.org/10.1038/s41598-022-23846-x

Ejemplares similares